Cytochrome P450 Induction by Rifampicin in Healthy Subjects: Determination Using the Karolinska Cocktail and the Endogenous CYP3A4 Marker 4β-Hydroxycholesterol-Reference-Cited by-同舟云学术

Cytochrome P450 Induction by Rifampicin in Healthy Subjects: Determination Using the Karolinska Cocktail and the Endogenous CYP3A4 Marker 4β-Hydroxycholesterol

Published:2008-07-23 Issue:5 Volume:84 Page:589-594
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Kanebratt KP,Diczfalusy U,Bäckström T,Sparve E,Bredberg E,Böttiger Y,Andersson TB,Bertilsson L

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference33 articles.

1. The karolinska cocktail for phenotyping of five human cytochrome P450 enzymes

2. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin

3. The mechanism of the warfarin-rifampin drug interaction in humans

4. Induction of polymorphic 4′-hydroxylation of S-mephenytoin by rifampicin.

5. Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic Metabolic Enzyme Activity with Endogenous Substances-current Status, Challenges and Limitations;Current Drug Metabolism;2024-08-16

2. Pregnane X receptor activation induces liver enlargement and regeneration and simultaneously promotes the metabolic activity of CYP3A1/2 and CYP2C6/11 in rats;Basic & Clinical Pharmacology & Toxicology;2024-06-17

3. Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: Alterations of gene expression, microsomal activity, and pharmacokinetics;Pharmacology Research & Perspectives;2024-04-21

4. Assessing Pleiotropic Effects of a Mixed-mode Perpetrator Drug Rifampicin by Multiple Endogenous Biomarkers in Dogs;Drug Metabolism and Disposition;2023-12-12

5. Influence of Rifamycin on Survival in Patients with Concomitant Lung Cancer and Pulmonary Tuberculosis;Biomedicines;2023-11-24